| 000 | 01637 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515004349.0 | ||
| 264 | 0 | _c20060427 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a0090-8258 | ||
| 024 | 7 |
_a10.1016/j.ygyno.2005.09.036 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSeiden, Michael V | |
| 245 | 0 | 0 |
_aA phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer. _h[electronic resource] |
| 260 |
_bGynecologic oncology _cApr 2006 |
||
| 300 |
_a55-61 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadverse effects |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xdrug therapy |
| 650 | 0 | 4 |
_aOrganoplatinum Compounds _xpharmacology |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSesquiterpenes _xadverse effects |
| 700 | 1 | _aGordon, Alan N | |
| 700 | 1 | _aBodurka, Diane C | |
| 700 | 1 | _aMatulonis, Ursula A | |
| 700 | 1 | _aPenson, Richard T | |
| 700 | 1 | _aReed, Eddie | |
| 700 | 1 | _aAlberts, Dave S | |
| 700 | 1 | _aWeems, Garry | |
| 700 | 1 | _aCullen, Michael | |
| 700 | 1 | _aMcGuire, William P | |
| 773 | 0 |
_tGynecologic oncology _gvol. 101 _gno. 1 _gp. 55-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ygyno.2005.09.036 _zAvailable from publisher's website |
| 999 |
_c15886757 _d15886757 |
||